Sickle Cell Disorders clinical trials at UC Health
1 in progress, 1 open to new patients
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell...
open to eligible people ages 6 years and up
This is an open label extension study in subjects with Sickle Cell Disease (SCD) who have completed the double blind Phase 3 study (B5201002).
at UC Davis